Increased blood IL-6 is a common indicator of systemic inflammation of asthma and COPD, suggesting the therapeutic potential of IL-6 antagonists in COPD emphysema and associated complications (33–35). This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.